FlowView Diagnostics is providing accurate and fast monitoring of the blood, saving lives and reducing healthcare costs
FlowView Diagnostics has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in June 2022.
FlowView Diagnostics's investors include NLC, Amatis.
FlowView Diagnostics is headquartered in Amsterdam, The Netherlands.
FlowView Diagnostics is providing accurate and fast monitoring of the blood, saving lives and reducing healthcare costs
FlowView Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FlowView Diagnostics — Funding & Investors." VCBacked, June 24, 2022, https://www.vcbacked.co/company/flowview-diagnostics. Accessed November 14, 2026.
VCBacked. (2022). FlowView Diagnostics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/flowview-diagnostics
{{cite web |title=FlowView Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/flowview-diagnostics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at FlowView Diagnostics? Request a listing update